Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer
Genes & Genomics · 2024
DOI: 10.1007/s13258-024-01517-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Genomics, 2024. Verfasst von Yang Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Postdoctoral Mobile Station of Heilongjiang University of Traditional Chinese Medicine, Harbin, 150040, Chin…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, NF-kappa B, Tripartite Motif Proteins, Signal Transduction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Ovarian cancer (OC) is the second most commonly seen cancer in the US, and patients with OC are commonly diagnosed in the advanced stage. Research into the molecular mechanisms and potential therapeutic targets of OC is becoming increasingly urgent. In our study, we worked to discover the role of TRIM44 in OC development. OBJECTIVE: This study explored whether the overexpression of TRIM44 mediates the NF-kB pathway to promote the progression of OC. METHODS: A TRIM44 overexpression model was constructed in SKOV3 cells, and the proliferation ability of the cells was detected using the CCK-8 assay. The migration healing ability of cells was detected using cell scratch assay. Cell migration and invasion were detected using Transwell nesting. TUNEL was applied to detect apoptosis, and ELISA and western blot were used to detect the expression of NF-κB signaling pathway proteins. The pathological changes of the tumor tissues were observed using HE staining in a mouse ovarian cancer xenograft model. Immunofluorescence double staining, RT-PCR, and western blot were used to determine the expression of relevant factors in tumour tissues. RESULTS: TRIM44 overexpression promoted the proliferation, migration, and invasion of SKOV3 cells in vitro and inhibited apoptosis while enhancing the growth of tumours in vivo. TRIM44 regulated the NF-κB signaling pathway. CONCLUSIONS: TRIM44 overexpression can regulate the NF-κB signaling pathway to promote the progression of OC, and TRIM44 may be a potential therapeutic target for OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Postdoctoral Mobile Station of Heilongjiang University of Traditional Chinese Medicine, Harbin, 150040, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, 150040, Harbin, China.
- Department of Obstetrics and Gynecology, Heilongjiang University of Chinese Medicine, Harbin, 150040, China.
- Biological Science and Technology Department, Heilongjiang Vocational College for Nationalities, Harbin, 150066, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, 150040, Harbin, China. hanfengjuan2004@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yu, Y., Li, S., Sun, J., Wang, Y., Xie, L., Guo, Y., Li, J., & Han, F. (2024). Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer. Genes & Genomics. https://doi.org/10.1007/s13258-024-01517-7
Vancouver
Yu Y, Li S, Sun J, Wang Y, Xie L, Guo Y, et al. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer. Genes & Genomics. 2024. doi:10.1007/s13258-024-01517-7
BibTeX
@article{Yu2024,
author = {Yu, Yang and Li, ShiYing and Sun, Jialin and Wang, Yu and Xie, LiangZhen and Guo, Ying and Li, Jia and Han, FengJuan},
title = {Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer},
journal = {Genes & Genomics},
year = {2024},
doi = {10.1007/s13258-024-01517-7}
}
EUVIMED